Let's hope that people have the common sense to distinguish between one thing and another -
Dendreon being hammered because of issues that have, maybe, perhaps, SOME potential future commonality with Cvac's passage to market;
and Dendreon being hammered because of this investigation, which has nothing at all to do with the drugs but rather the management.
Let's hope.
Let's hope that people have the common sense to distinguish...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $562.6M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 39.5¢ | $754.0K | 1.894M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 40712 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 2454 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |